CBDG THC Farmaceuticals Inc (PK)

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

March 19, 2015 (February 15, 2015)

THC FARMACEUTICALS, INC.

formerly, City Media, Inc.

(Exact name of registrant as specified in its charter)

UTAH

(State or other jurisdiction of incorporation)

000-54754

(Commission File No.)

7170 E. McDonald Drive, Suite 3

Scottsdale, Arizona 85253

(Address of principal executive offices and Zip Code)

5635 N. Scottsdale Road

Scottsdale, Arizona 85250

(Former Address of principal executive offices and Zip Code if change since last report)

(480) 725-9060

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

---

---

On March 12, 2015, we obtained an Assignment of Application from Sadia Barrameda ("Barrameda") wherein Barrameda assigned us 80% of the ownership interest in the following patent applications:  (1) U.S. Patent Application No. 14/564,672, filed with the United States Patent and Trademark Office on December 9, 2014; and, (2) PCT Application No. PCT/US15/18820, filed with the United States Patent and Trademark Office receiving office on March 4, 2015 (collectively the "Patent Applications") in consideration of $8,532.  Barrameda will continue to retain a 20% interest in the Patent Applications.

ITEM 5.03

AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR.

On February 15, 2015, we filed amended articles of incorporation with the Secretary of State of Utah changing our name to THC Farmaceuticals, Inc.  Our trading symbol will continue to be CBDG.

On March 10, 2015, we were advised by our patent attorneys that the documents required for filing a U.S. Utility Patent (No. 14/638,939) were filed with the United States Patent and Trademark Office on March 10, 2015.  The invention relates generally to digital currency wallets, and specifically to wallets that securely hold multiple currencies.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated this 19^th day of March, 2015.

-2-

Exhibit 3.1

Exhibit 10.1

ASSIGNMENT OF APPLICATION

WHEREAS, Sadia "Ross" Barrameda, hereinafter referred to as the ASSIGNOR, has invented certain Improvements relating to METHODS OF PRODUCING ANTIBODY-RICH CANNABIS AND HONEYSUCKLE PLANTS, said improvements being described and/or claimed in the following patent application(s):

U.S. Patent Application No. 14/564,672, filed with the USPTO on December 9, 2014; and

PCT Application No. PCT/US15/18820, filed with the USPTO receiving office on March 4, 2015;

AND WHEREAS, THC Farmaceuticals, Inc., whose address is 5635 N. Scottsdale Road, Scottsdale, AZ, 85250, hereinafter referred to as the ASSIGNEE, is desirous of acquiring the entire right, title and interest in and to said invention(s) and application(s), including any and all divisions and continuations thereof, any national entry filings from the PCT application, including any continuations and divisions thereof, and any and all Letters Patent which may be granted on any of the foregoing, including any and all renewals, reissues, and prolongations thereof;

NOW, THIS WITNESSETH that for and in consideration of One Dollar ($1.00) and other good and valuable consideration, the receipt whereof is hereby acknowledged, said ASSIGNOR hereby assigns, sells, and transfers to said ASSIGNEE and ASSIGNEE's assigns and legal representatives, the entire and exclusive right, title, and interest in and to said invention(s) and application(s), including any and all divisions and continuations thereof, and any and all Letters Patent which may be granted therefor, including any and all renewals, reissues, and prolongations thereof, said ASSIGNEE and ASSIGNEE's assigns and legal representatives to have, hold, exercise, and enjoy the said invention(s) and application(s), including any and all divisions and continuations thereof, and any and all Letters Patent which may be granted therefor, including any and all renewals, reissues, and prolongations thereof, with all the rights, powers, privileges, and advantages in anywise arising from or appertaining thereto, for and during the term or terms of any and all such Letters Patent when granted, including any and all renewals, reissues, and prolongations thereof, for the use and benefit of said ASSIGNEE and ASSIGNEE's assigns and legal representatives, in as ample and beneficial a manner to all intents and purposes as said ASSIGNOR might or could have held and enjoyed the same, if this assignment had not been made;

AND said ASSIGNOR hereby agrees to execute all papers that may be necessary to file applications in the United States and foreign countries for said invention(s) and to assign the same to said ASSIGNEE, or any assignee acquiring title to said invention(s), and to execute any other papers that may be needed in connection with filing said application(s) and securing Letters Patent thereon;

AND said ASSIGNOR authorizes and requests the Director of the Patent and Trademark Office to issue Letters Patent on said application(s), and on any and all divisions and continuations thereof, to said ASSIGNEE, ASSIGNEE's assigns and legal representatives, in accordance herewith.

---

Page 2

Assignment

IN TESTIMONY WHEREOF, this assignment is executed by said ASSIGNOR the day and year set forth below.

THC Farmaceuticals (PK) (USOTC:CBDG)
Historical Stock Chart
From Oct 2024 to Nov 2024

THC Farmaceuticals (PK) (USOTC:CBDG)
Historical Stock Chart
From Nov 2023 to Nov 2024